[{"address1": "545 Concord Avenue", "address2": "Suite 210", "city": "Cambridge", "state": "MA", "zip": "02138", "country": "United States", "phone": "857 702 9600", "website": "https://www.metaviatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Heon Kim  Hyung", "age": 48, "title": "CEO, President & Director", "yearBorn": 1977, "fiscalYear": 2025, "totalPay": 516466, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marshall H. Woodworth", "age": 67, "title": "Chief Financial Officer", "yearBorn": 1958, "fiscalYear": 2025, "totalPay": 405665, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mi-Kyung  Kim", "title": "Chief Scientific Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Homolka", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. W. Christopher Fang M.D.", "title": "Consulting Chief Medical Officer & Advisor", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael C. Pine", "age": 49, "title": "Senior Vice President of Business Development Advisor", "yearBorn": 1976, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.66, "open": 1.83, "dayLow": 1.55, "dayHigh": 1.96, "regularMarketPreviousClose": 1.66, "regularMarketOpen": 1.83, "regularMarketDayLow": 1.55, "regularMarketDayHigh": 1.96, "payoutRatio": 0.0, "beta": 0.279, "volume": 2351298, "regularMarketVolume": 2351298, "averageVolume": 264930, "averageVolume10days": 512010, "averageDailyVolume10Day": 512010, "bid": 1.6, "ask": 1.68, "bidSize": 1, "askSize": 1, "marketCap": 5436869, "fiftyTwoWeekLow": 1.54, "fiftyTwoWeekHigh": 23.1, "allTimeHigh": 1424940.0, "allTimeLow": 1.54, "fiftyDayAverage": 5.94062, "twoHundredDayAverage": 7.8981, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -10593794, "profitMargins": 0.0, "floatShares": 981536, "sharesOutstanding": 3315164, "sharesShort": 62409, "sharesShortPriorMonth": 19683, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0188, "heldPercentInsiders": 0.55505, "heldPercentInstitutions": 0.0478, "shortRatio": 0.24, "shortPercentOfFloat": 0.0319, "impliedSharesOutstanding": 3315164, "bookValue": 2.876, "priceToBook": 0.57023644, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -16216000, "trailingEps": -10.45, "lastSplitFactor": "1:11", "lastSplitDate": 1764892800, "enterpriseToEbitda": 0.615, "52WeekChange": -0.90964186, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 1.64, "targetHighPrice": 208.99998, "targetLowPrice": 40.0, "targetMeanPrice": 91.0, "targetMedianPrice": 57.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 14283000, "totalCashPerShare": 6.488, "ebitda": -17228000, "totalDebt": 79000, "quickRatio": 1.694, "currentRatio": 1.737, "debtToEquity": 1.248, "returnOnAssets": -0.58407, "returnOnEquity": -1.68181, "freeCashflow": -11055375, "operatingCashflow": -16310000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MTVA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 1.6505, "postMarketChange": 0.010500073, "regularMarketChange": -0.02, "regularMarketDayRange": "1.55 - 1.96", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 264930, "fiftyTwoWeekLowChange": 0.100000024, "fiftyTwoWeekLowChangePercent": 0.06493508, "fiftyTwoWeekRange": "1.54 - 23.1", "fiftyTwoWeekHighChange": -21.460001, "fiftyTwoWeekHighChangePercent": -0.9290044, "fiftyTwoWeekChangePercent": -90.96419, "dividendDate": 1577750400, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.45, "fiftyDayAverageChange": -4.30062, "fiftyDayAverageChangePercent": -0.72393453, "twoHundredDayAverageChange": -6.2581, "twoHundredDayAverageChangePercent": -0.7923551, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470403800000, "postMarketChangePercent": 0.64024836, "shortName": "MetaVia Inc.", "longName": "MetaVia Inc.", "corporateActions": [], "postMarketTime": 1771030616, "regularMarketTime": 1771016402, "exchange": "NCM", "messageBoardId": "finmb_630763379", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.20482, "regularMarketPrice": 1.64, "displayName": "MetaVia", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]